E
Eliane Gluckman
Researcher at University of Paris
Publications - 694
Citations - 48573
Eliane Gluckman is an academic researcher from University of Paris. The author has contributed to research in topics: Transplantation & Bone marrow. The author has an hindex of 112, co-authored 679 publications receiving 46415 citations. Previous affiliations of Eliane Gluckman include Medical College of Wisconsin & Leiden University.
Papers
More filters
Journal ArticleDOI
New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients
N Parquet,O Reigneau,H Humbert,M Guignard,Patricia Ribaud,Gérard Socié,Agnès Devergie,Hélène Espérou,Eliane Gluckman +8 more
TL;DR: It is concluded that doubling the last i.v. dose during the switch to oral administration of Neoral gives the best therapeutic range concentration and should be recommended for graft-versus-host prevention.
Journal Article
Cord blood transplantation (cbt) in hemoglobinopathies
R. Miniero,V. Rochau,P. Saracco,F. Locatelli,B. Brichard,Arnon Nagler,I. Roberts,I. Yaniv,M. Beksac,F. Bernaudin,Eliane Gluckman +10 more
Journal ArticleDOI
Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants.
Vanderson Rocha,Marie-Vonique Carmagnat,Sylvie Chevret,Odile Flinois,Henrique Bittencourt,Helene Esperou,Federico Garnier,Patricia Ribaud,Agnès Devergie,Gérard Socié,Liliane Dal'Cortivo,Jean-Pierre Marolleau,Dominique Charron,Eliane Gluckman,Claire Rabian +14 more
TL;DR: A high cell dose of CD3/CD8 is associated with faster neutrophil recovery, whereas a high cell doses of CD4+ cells increases the incidence of acute GVHD, and a high number of nucleated cells and CD34+ cells infused was associated with decreased risk of chronic GV HD and improved survival.
Journal ArticleDOI
A multicenter randomized study comparing cyclosporin-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia
Eliane Gluckman,Hélène Esperou-Bourdeau,André Baruchel,Michel Boogaerts,Jean Briere,Daniel Donadio,Guy Leverger,Michel Leporrier,Josy Reiffers,Maud Janvier,Mauricette Michallet,Pierre Stryckmans +11 more
TL;DR: Initial treatment of SAA with either CsA or ATG-PDN followed by cross-over therapy for nonresponders produced comparable response and survival rates.
Journal ArticleDOI
ABO-mismatched marrow processing for transplantation: results of 114 procedures and analysis of immediate adverse events and hematopoietic recovery
Jérôme Larghero,Delphine Rea,Helene Esperou,Nicole Biscay,Marie-Noelle Maurer,Marie-Noëlle Lacassagne,Brigitte Ternaux,R. Traineau,Karima Yakouben,Christine Dosquet,Gérard Socié,Eliane Gluckman,Marc Benbunan,Jean-Pierre Marolleau +13 more
TL;DR: Technical and clinical data obtained after bone marrow processing with a continuous‐flow cell separator (Cobe Spectra, Gambro BCT) are reported.